Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Esther Sathya Bama Benjamin, Niveditha Ravindra, Bharathi Murugan Rajamani, Senthamizhselvi Anandan, Bagavathi Kausalya, Vidya Veldore, Vikram Mathews, Shaji Ramachandran Velayudhan & Poonkuzhali Balasubramanian. (2021) BCR-ABL1 kinase domain mutation analysis by next generation sequencing detected additional mutations in chronic myeloid leukemia patients with suboptimal response to imatinib. Leukemia & Lymphoma 62:6, pages 1528-1531.
Read now
Read now
Nikhil Patkar, Kiran Ghodke, Swapnali Joshi, Shruti Chaudhary, Russel Mascerhenas, Sona Dusseja, Shashikant Mahadik, Sheetal Gaware, Prashant Tembhare, Sumeet Gujral, Sharayu Kabre, Pratibha Kadam-Amare, Hasmukh Jain, Uma Dangi, Bhausaheb Bagal, Navin Khattry, Manju Sengar, Brijesh Arora, Gaurav Narula, Shripad Banavali, Hari Menon & Papagudi Ganesan Subramanian. (2016) Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistance. Leukemia & Lymphoma 57:11, pages 2653-2660.
Read now
Read now
Bahram Chahardouli, Farhad Zaker, Seied Asadollah Mousavi, Zeinab Saffari, Fatemeh Nadali, Mohammadreza Ostadali, Habibeh Ghadimi, Kamran Alimoghaddam, Ardeshir Ghavamzade & Shahrbano Rostami. (2013) Detection of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on imatinib. Hematology 18:6, pages 328-333.
Read now
Read now
Bahram Chahardouli, Farhad Zaker, Seied Asadollah Mousavi, Ahmad Kazemi, Mohammadreza Ostadali, Fatemeh Nadali, Shahrbano Rostami, Kamran Alimoghaddam & Ardeshir Ghavamzade. (2013) Evaluation of T315I mutation frequency in chronic myeloid leukemia patients after imatinib resistance. Hematology 18:3, pages 158-162.
Read now
Read now
Articles from other publishers (12)
Omalbanin Mokhlesi, Mohammad Hadi Sadeghian, Arezoo Shajiei, Maryam Sheikhi, Payam Siyadat, Mohammad Mehdi Kooshyar, Hossein Rahimi, Nafiseh Amini, Maliheh Dadgar Moghadam, Hossein Ayatollahi, Seyyede Fatemeh Shams & Zahra Khoshnegah. (2023) Frequency of T315I Mutation in Patients with Chronic Myeloid Leukemia Before and During Imatinib Treatment: A Study in North-East of Iran. Journal of Advances in Medical and Biomedical Research 31:146, pages 244-249.
Crossref
Crossref
Atreye Majumdar, Rahul Katara, Avshesh Mishra, Aastha Gupta, Deepak K. Sharma, Aman K. Srivastava, Shivani Sharma, Ankita Jaiswal, Mallika Dixit, Vipin Kumar, Sachin Kumar, Varun Kumar, Rahul Sharma & Sambit K. Mohanty. (2022) A Retrospective Analysis of BCR-ABL1 Kinase Domain Mutations in the Frontline Drug Intolerant or Resistant Chronic Myeloid Leukemia Patients: An Indian Experience from a High-End Referral Laboratory. South Asian Journal of Cancer.
Crossref
Crossref
Bushra Kaleem, Sadaf Shahab, Uzma Zaidi & Tahir Sultan Shamsi. (2022) P‐Loop mutations—Negative prognosticators in tyrosine kinase inhibitors resistant chronic myeloid leukemia patients. International Journal of Laboratory Hematology 44:3, pages 538-546.
Crossref
Crossref
K Ghosh. (2022) Tyrosine kinase domain mutations in chronic myelogenous leukemia patients: Indian perspective. Journal of Postgraduate Medicine 68:2, pages 70.
Crossref
Crossref
Sonu Kumar Gupta, Priyanka Singh, Ravindresh Chhabra & Malkhey Verma. (2021) Novel pharmacological approach for the prevention of multidrug resistance (MDR) in a human leukemia cell line. Leukemia Research 109, pages 106641.
Crossref
Crossref
Bharathi M. Rajamani, Esther Sathya Bama Benjamin, Aby Abraham, Sukanya Ganesan, Kavitha M. Lakshmi, Senthamizhselvi Anandan, Sreeja Karathedath, Savitha Varatharajan, Ezhilpavai Mohanan, Nancy Beryl Janet, Vivi M. Srivastava, Shaji Ramachandran Velayudhan, Uday P. Kulkarni, Anup J. Devasia, N. A. Fouzia, Anu Korula, Biju George, Alok Srivastava, Vikram Mathews & Poonkuzhali Balasubramanian. (2020) Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients. Scientific Reports 10:1.
Crossref
Crossref
Sonu Kumar Gupta, Priyanka Singh, Villayat Ali & Malkhey Verma. (2020) Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy. Oncology Reviews 14:2.
Crossref
Crossref
Hawk Kim, SooHyun Kim, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, Jae-Yong Kwak, Ho-Young Yhim, Sung-Hyun Kim, Young Rok Do, Sukjoong Oh, Sung-Eun Lee, Saengsuree Jootar, Jiu Wei Cui & Dong-Wook Kim. (2018) Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic–Phase Chronic Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia 18:10, pages e391-e399.
Crossref
Crossref
A. K. Arun, A. Senthamizhselvi, S. Mani, K. Vinodhini, N. B. Janet, K. M. Lakshmi, A. Abraham, B. George, A. Srivastava, V. M. Srivastava, V. Mathews & P. Balasubramanian. (2017)
Frequency of rare
BCR-ABL1
fusion transcripts in chronic myeloid leukemia patients
. International Journal of Laboratory Hematology 39:3, pages 235-242.
Crossref
Crossref
Prasanth GanesanLalit Kumar. (2017) Chronic Myeloid Leukemia in India. Journal of Global Oncology 3:1, pages 64-71.
Crossref
Crossref
Simona Soverini, Susan Branford, Franck E. Nicolini, Moshe Talpaz, Michael W.N. Deininger, Giovanni Martinelli, Martin C. Müller, Jerald P. Radich & Neil P. Shah. (2014) Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia. Leukemia Research 38:1, pages 10-20.
Crossref
Crossref
Abdalla AwidiNidaa AbabnehAhmad MagablahNazzal BsoulRazan MeflehLina MareiSalah Abbasi. (2012) ABL Kinase Domain Mutations in Patients with Chronic Myeloid Leukemia in Jordan. Genetic Testing and Molecular Biomarkers 16:11, pages 1317-1321.
Crossref
Crossref